Evidence map›Paper›PMID 32313829›Full record

ArticleAlzheimer's & dementia (Amsterdam, Netherlands)2020

Amyloid β influences the relationship between cortical thickness and vascular load.

Thomas D Parker, David M Cash, Christopher A Lane, Kirsty Lu, Ian B Malone, Jennifer M Nicholas, Sarah-Naomi James, Ashvini Keshavan, Heidi Murray-Smith, Andrew Wong and 8 more

Open access · goldAbstract read
In one paragraph

Article in Alzheimer's & dementia (Amsterdam, Netherlands), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 4 institutions in 1 country.

Thomas D ParkerDepartment of Neurodegenerative Disease The Dementia Research Centre, UCL Queen Square Institute of Neurology London UK.
David M CashDepartment of Neurodegenerative Disease The Dementia Research Centre, UCL Queen Square Institute of Neurology London UK.
Christopher A LaneDepartment of Neurodegenerative Disease The Dementia Research Centre, UCL Queen Square Institute of Neurology London UK.
Kirsty LuDepartment of Neurodegenerative Disease The Dementia Research Centre, UCL Queen Square Institute of Neurology London UK.
Ian B MaloneDepartment of Neurodegenerative Disease The Dementia Research Centre, UCL Queen Square Institute of Neurology London UK.
Jennifer M NicholasDepartment of Neurodegenerative Disease The Dementia Research Centre, UCL Queen Square Institute of Neurology London UK.
Sarah-Naomi JamesMRC Unit for Lifelong Health and Ageing at UCL London UK.
Ashvini KeshavanDepartment of Neurodegenerative Disease The Dementia Research Centre, UCL Queen Square Institute of Neurology London UK.
Heidi Murray-SmithDepartment of Neurodegenerative Disease The Dementia Research Centre, UCL Queen Square Institute of Neurology London UK.
Andrew WongMRC Unit for Lifelong Health and Ageing at UCL London UK.
Sarah M BuchananDepartment of Neurodegenerative Disease The Dementia Research Centre, UCL Queen Square Institute of Neurology London UK.
Sarah E KeussDepartment of Neurodegenerative Disease The Dementia Research Centre, UCL Queen Square Institute of Neurology London UK.
Carole H SudreDepartment of Neurodegenerative Disease The Dementia Research Centre, UCL Queen Square Institute of Neurology London UK.
David L ThomasLeonard Wolfson Experimental Neurology Centre, Queen Square Institute of Neurology UCL London UK.
Sebastian J CrutchDepartment of Neurodegenerative Disease The Dementia Research Centre, UCL Queen Square Institute of Neurology London UK.
Nick C FoxDepartment of Neurodegenerative Disease The Dementia Research Centre, UCL Queen Square Institute of Neurology London UK.
Marcus RichardsMRC Unit for Lifelong Health and Ageing at UCL London UK.
Jonathan M SchottDepartment of Neurodegenerative Disease The Dementia Research Centre, UCL Queen Square Institute of Neurology London UK.
National Hospital for Neurology and Neurosurgery · GBUK Dementia Research Institute · GBUniversity College London · GBLondon School of Hygiene & Tropical Medicine · GB

Funding

British Heart Foundation PG/17/90/33415Medical Research Council MC_UU_00019/3Medical Research Council MC_UU_12019/1Medical Research Council MC_UU_12019/3Wellcome Trust
6 · The paper itself

Abstract

introductionCortical thickness has been proposed as a biomarker of Alzheimer's disease (AD)- related neurodegeneration, but the nature of its relationship with amyloid beta (Aβ) deposition and white matter hyperintensity volume (WMHV) in cognitively normal adults is unclear.

methodsWe investigated the influences of Aβ status (negative/positive) and WMHV on cortical thickness in 408 cognitively normal adults aged 69.2 to 71.9 years who underwent

resultsHigher WMHV, but not Aβ status, predicted lower cortical thickness across all participants, in all ROIs. Conversely, when Aβ-positive participants were considered alone, higher WMHV predicted higher cortical thickness in a temporal AD-signature region. DISCUSSION: WMHV may differentially influence cortical thickness depending on the presence or absence of Aβ, potentially reflecting different pathological mechanisms.

Indexed as

Alzheimer's diseaseamyloidbiomarkercognitively normalcortical thicknessMRC National Survey of Health and Developmentneurodegenerationwhite matter hyperintensities

Identifiers

PMID32313829
PMCPMC7163924
OpenAlexW3016612602

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.